George Tidmarsh, the head of the FDA’s drug division, resigned on Sunday after he was placed on leave Friday, “after the Office of the General Counsel and the Office of the Inspector General were notified of serious concerns about his personal conduct,” Emily Hilliard, an HHS spokeswoman, told ABC News in a statement. Tidmarsh said… The post FDA Drug Unit chief resigns as he is sued appeared first on Drug Discovery and Development.| Drug Discovery and Development
The FDA has notified manufacturers that it intends to pursue compliance actions against unapproved ingestible fluoride prescription drugs for children. In a Halloween press release, the agency said it was tightening a long-standing regulatory gap for products that have been sold for decades without new-drug approval. In it, Human Services Secretary Robert F. Kennedy Jr.… The post FDA moves against unapproved ingestible fluoride drugs for kids, citing risk-benefit concerns appeared first on ...| Drug Discovery and Development
This story was originally published by Yale e360 and is reproduced here as part of the Climate Desk collaboration. Each year, the Sweeney Center for Public Policy at Rowan University in New Jersey hosts a conference on the state’s current and future energy landscape. In 2023 and 2024, the gatherings focused heavily on the rapidly accelerating development of […]| Mother Jones
Learn more about and read DirectTrust's pledge to CMS in response to their Health Tech Ecosystem initiative.| DirectTrust
The 2024 DirectTrust Annual Conference was an unforgettable gathering of industry leaders working together toward the Future of Trust in Health.| DirectTrust
The full data set from our in-depth investigation into mass shootings.| Mother Jones